Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese Biotech Start-Up Specializes In Regenerating Skin

This article was originally published in PharmAsia News

Executive Summary

Japanese biotech Two Cells is specializing in regenerative medicine, beginning with plasters and artificial scalps made with regenerated skin cells. The research for the start-up, a spin-off of Hiroshima University, is being developed at Kobe University and other institutions. Two Cells' specialty has meant it is involved in cell culturing and non-medical products such as software. The scalp work involves using cultured epidermal cells attached to a biological plaster bandage to be placed over damaged skin to promote healing. (Click here for more - a subscription may be required

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069742

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel